IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 310 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $844,000 | +30.7% | 22,794 | +58.7% | 0.07% | +56.5% |
| Q1 2021 | $646,000 | -23.5% | 14,360 | -19.3% | 0.05% | -68.3% |
| Q3 2020 | $844,000 | +137.1% | 17,795 | +194.4% | 0.14% | +253.7% |
| Q2 2020 | $356,000 | +1.7% | 6,044 | +11.1% | 0.04% | +95.2% |
| Q2 2019 | $350,000 | -52.3% | 5,439 | -39.8% | 0.02% | -50.0% |
| Q1 2019 | $734,000 | +10.0% | 9,041 | -40.3% | 0.04% | +16.7% |
| Q1 2018 | $667,000 | +77.4% | 15,132 | +102.4% | 0.04% | +80.0% |
| Q4 2017 | $376,000 | -70.1% | 7,476 | -69.8% | 0.02% | -67.7% |
| Q3 2017 | $1,257,000 | +513.2% | 24,789 | +648.0% | 0.06% | +113.8% |
| Q4 2015 | $205,000 | – | 3,314 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |